Patienter med type 2 diabetes mellitus var kvalificerede til at deltage i undersøgelsen, forudsat at hæmoglobin A1C ved uge - 4 ikke var ≤10%.
Patients with type 2 diabetes mellitus were eligible to participate provided hemoglobin A1C at Week -4 was not ≤ 10%.